BRIEF-FDA approves Genentech's MS drug Ocrevus
* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Nov 28 Privately held Silverback Exploration LLC will sell oil and gas assets for $855 million to Centennial Resource Development Inc, which is backed by energy private equity fund Riverstone Holdings LLC.
The assets have net production of about 3,500 barrels of oil equivalents per day, Centennial said. (Reporting by Anet Josline Pinto in Bengaluru; Editing by Savio D'Souza and Martina D'Couto)
LIMA, March 28 A Boeing jet operated by Peruvian Airlines caught fire on Tuesday while landing at an airport near the Andean town of Jauja in central Peru after it swerved on the runway, but there were no serious injuries, a government minister said.
March 28 The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues.